Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.84

+3.8%

Nov 24 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (22242)	6/15/1998 6:18:00 AM
From: Henry Niman	Read Replies (1) of 32384

PB, Although PI's help KS, I did notice that the small study did not find any complete remissions. LGND's study has indicated that Panretin is effective against refractory patients and is independent of responses to PI's. The small study suggested an indirect effect (bolstering of the immune system) for PI related improvements and LGND's data suggested that Panretin works by an independent mechanism. Thus, AIDS patients who are in better health and have a partial remission in KS may in fact be an expanding market because they live longer and their KS is improved, but still present.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next